This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sugihara, E. Articles by Miwa, M. Search for Related Content PubMed PubMed Citation Articles by Sugihara, E. Articles by Miwa, M.

Suppression of Centrosome Amplification after DNA Damage Depends on p27 Accumulation

¹ Nagahama Institute of Bio-Science and Technology, Shiga, Japan; ² Graduate School of Comprehensive Human Science, University of Tsukuba, Ibaraki, Japan; ³ Department of Cell Biology, University of Cincinnati College of Medicine, Cincinnati, Ohio; ⁴ Department of Developmental Biology, Center for Translational and Advanced Animal Research on Human Disease, Tohoku University, Sendai, Japan; ⁵ Department of Molecular and Cellular Biology, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan; ⁶ Department of Tumour Genetics, Deutsches Krebsforschungszentrum, Heidelberg, Germany; and ⁷ Department of Tumor Genetics and Biology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

Requests for reprints: Masanao Miwa, Nagahama Institute of Bio-Science and Technology, 1266 Tamura-cho, Nagahama, Shiga, 526-0829, Japan. Phone: 81-749-64-8112; Fax: 81-749-64-8138; E-mail: m_miwa{at}nagahama-i-bio.ac.jp.

The centrosome plays a fundamental role in cell division, cell polarity, and cell cycle progression. Centrosome duplication is mainly controlled by cyclin-dependent kinase 2 (CDK2)/cyclin E and cyclin A complexes, which are inhibited by the CDK inhibitors p21^Cip1 and p27^Kip1. It is thought that abnormal activation of CDK2 induces centrosome amplification that is frequently observed in a wide range of aggressive tumors. We previously reported that overexpression of the oncogene MYCN leads to centrosome amplification after DNA damage in neuroblastoma cells. We here show that centrosome amplification after -irradiation was caused by suppression of p27 expression in MYCN-overexpressing cells. We further show that p27^–/– and p27^+/– mouse embryonic fibroblasts and p27-silenced human cells exhibited a significant increase in centrosome amplification after DNA damage. Moreover, abnormal mitotic cells with amplified centrosomes were frequently observed in p27-silenced cells. In response to DNA damage, the level of p27 gradually increased in normal cells independently of the ataxia telangiectasia mutated/p53 pathway, whereas Skp2, an F-box protein component of an SCF ubiquitin ligase complex that targets p27, was reduced. Additionally, p27 levels in MYCN-overexpressing cells were restored by treatment with Skp2 small interfering RNA, indicating that down-regulation of p27 by MYCN was due to high expression of Skp2. These results suggest that the accumulation of p27 after DNA damage is required for suppression of centrosome amplification, thereby preventing chromosomal instability. (Cancer Res 2006; 66(8): 4020-9)

This article has been cited by other articles:

				A. S. Hemerly, S. G. Prasanth, K. Siddiqui, and B. Stillman Orc1 Controls Centriole and Centrosome Copy Number in Human Cells Science, February 6, 2009; 323(5915): 789 - 793. [Abstract] [Full Text] [PDF]

				S. R. Payne, S. Zhang, K. Tsuchiya, R. Moser, K. E. Gurley, G. Longton, J. deBoer, and C. J. Kemp p27kip1 Deficiency Impairs G2/M Arrest in Response to DNA Damage, Leading to an Increase in Genetic Instability Mol. Cell. Biol., January 1, 2008; 28(1): 258 - 268. [Abstract] [Full Text] [PDF]

				A. D. Slack, Z. Chen, A. D. Ludwig, J. Hicks, and J. M. Shohet MYCN-Directed Centrosome Amplification Requires MDM2-Mediated Suppression of p53 Activity in Neuroblastoma Cells Cancer Res., March 15, 2007; 67(6): 2448 - 2455. [Abstract] [Full Text] [PDF]